Zimmer Biomet Announces Leadership Transition
WARSAW, Ind., Aug. 22, 2023 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced the appointment of Ivan Tornos as President and Chief Executive Officer (CEO) and election to the Board of Directors, effective immediately. Mr. Tornos has most recently served as Chief Operating Officer of Zimmer Biomet, a role he has held since early 2021. He takes over as President and CEO from Bryan Hanson, who has served as the Company's President and CEO since late 2017 and Chairman since 2021, and is departing to take on another CEO role.
- Mr. Tornos has most recently served as Chief Operating Officer of Zimmer Biomet, a role he has held since early 2021.
- Mr. Tornos joined Zimmer Biomet in November 2018 as Group President, Orthopedics and a year later was named Group President, Global Businesses and the Americas.
- His deep expertise in the medtech sector, commercial prowess and proven leadership experience make him the ideal leader for Zimmer Biomet as we move into our next phase of innovation and growth," said Mr. Begley.
- During his tenure at Zimmer Biomet, he spearheaded the Company's transformation, reshaping the mission, culture, corporate strategy, quality, compliance, operations and market performance.